Fig. 1From: Antibody development for preventing the human respiratory syncytial virus pathologyTimeline of antibodies therapies since the discovery of hRSV as human pathogen. Advances and implementation of different strategies that use antibodies to promote the clearance of hRSV since the virus was first discovered in 1956Back to article page